No need to break away: Armenia will have to choose between the EU and the EAEU
It will be difficult for Yerevan to permanently keep the two-vector approach to this issue, the Russian Foreign Ministry ...
FiercePharma9h
Novartis debuts €40M viral vector plant in Slovenia, part of €3.5B investment push in the country
Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 ...
Pharmabiz15h
CSL Behring's gene therapy Hemgenix four years post-infusion data continue to show sustained efficacy and safety in adults with haemophilia B
CSL Behring's gene therapy Hemgenix four years post-infusion data continue to show sustained efficacy and safety in adults with haemophilia B: King of Prussia, Pennsylvania Monday ...
How can businesses drive value and innovation with trusted AI?
Trusted AI cannot be delivered without trusted data which should be curated, integrated and harmonized across an organization ...